4//SEC Filing
Courtney Jeffrey 4
Accession 0001209191-09-012164
CIK 0001398161other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:14 PM ET
Size
7.9 KB
Accession
0001209191-09-012164
Insider Transaction Report
Form 4
Courtney Jeffrey
Director
Transactions
- Disposition from Tender
Common Stock
2009-02-25−106,149→ 0 total(indirect: See footnote.) - Disposition from Tender
Common Stock
2009-02-25−1,523,210→ 0 total(indirect: See footnote.)
Footnotes (3)
- [F1]The shares were tendered in a tender offer by Boxford Subsidiary Corporation for consideration of (1) $2.00 per common share in cash, plus (2) the contractual right to receive up to an additional $4.55 per common share in contingent cash payments if specified regulatory and commercial milestones are achieved within agreed upon time periods.
- [F2]Shares held by VenGrowth III Investment Fund. Mr. Courtney is a General Partner of VenGrowth III Investment Fund and, as such, may be deemed to hold voting and dispositive power with respect to all shares of common stock held by VenGrowth III Investment Fund. Mr. Courtney disclaims beneficial ownership of the shares held by VenGrowth III Investment Fund except to the extent of his pecuniary interest, if any, in such shares.
- [F3]Shares held by VenGrowth Advanced Life Sciences Fund. Mr. Courtney is a General Partner of VenGrowth Advanced Life Sciences Fund and, as such, may be deemed to hold voting and dispositive power with respect to all shares of common stock held by VenGrowth Advanced Life Sciences Fund. Mr. Courtney disclaims beneficial ownership of the shares held by VenGrowth Advanced Life Sciences Fund except to the extent of his pecuniary interest, if any, in such shares.
Documents
Issuer
Targanta Therapeutics Corp.
CIK 0001398161
Entity typeother
Related Parties
1- filerCIK 0001413352
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:14 PM ET
- Size
- 7.9 KB